HomeShopCJC-1295 with DAC
Growth & Endocrine Signalling

CJC-1295 with DAC

Research-use product information

A synthetic GHRH analogue incorporating a Drug Affinity Complex for peptide pharmacokinetics research.

£25.00
Direct bank transferResearch-use confirmationDelivery details at checkout
Important: For research and laboratory purposes only. Not intended for human or veterinary use.
Product overview

Research information

CJC-1295 with DAC is a synthetic peptide analogue developed from growth hormone-releasing hormone and incorporates a Drug Affinity Complex designed to facilitate albumin binding in experimental models.

It is investigated in research involving GHRH receptor signalling, growth hormone-related pathways, peptide pharmacokinetics and neuroendocrine mechanisms.

Product information

CompoundCJC-1295 with DAC
FormatLyophilised powder
ModificationDrug Affinity Complex (DAC)
Research areaGHRH receptor signalling, peptide pharmacokinetics & endocrine pathways
Available options2mg / 5mg
Handling guidance

Storage information

Storage conditions vary by compound and formulation. Always refer to compound-specific stability data and the product packaging.

Unreconstituted / lyophilised peptides

  • Store at −20°C or below for long-term storage.
  • Keep sealed and protected from moisture, heat and direct light.
  • Allow to reach room temperature before opening after removal from cold storage.
  • Avoid unnecessary temperature fluctuations.
  • Some products may be suitable for short-term refrigeration at 2–8°C depending on the compound.

Reconstituted peptides

  • Store refrigerated at 2–8°C where appropriate for the specific peptide and research protocol.
  • Keep protected from direct light and minimise unnecessary agitation.
  • Avoid repeated temperature changes.
  • For frozen storage protocols, use suitable aliquots to reduce repeat freeze-thaw cycles.
  • Use compound-specific stability data rather than a universal expiry period.